Unaudited Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue	$ 189,918	$ 169,156	$ 558,090	$ 494,358
Cost of goods sold (excluding amortization of purchased technology)	47,719	43,291	135,849	131,131
Gross profit	142,199	125,865	422,241	363,227
Operating expenses:
Sales, marketing and administrative	113,746	102,085	348,820	306,243
Research and development	9,068	7,248	28,590	24,654
Amortization of intangible assets	3,071	4,974	10,541	14,263
Goodwill and Intangible Asset Impairment	0	0	10,708	0
Litigation Award	0	0	30,000	0
Total operating expenses	125,885	114,307	428,659	345,160
Interest and other expense, net:
Interest income	241	157	691	560
Interest expense	(6,965)	(6,712)	(20,809)	(20,396)
Other income (expense), net	(2,489)	3,137	(2,318)	2,937
Total interest and other expense, net	(9,213)	(3,418)	(22,436)	(16,899)
Income (loss) before income taxes	7,101	8,140	(28,854)	1,168
Income tax (expense) benefit	(9,088)	(860)	4,065	(20)
Consolidated net (loss) income	(1,987)	7,280	(24,789)	1,148
Add back net loss attributable to noncontrolling interests	(157)	(231)	(595)	(745)
Net (loss) income attributable to NuVasive, Inc.	$ (1,830)	$ 7,511	$ (24,194)	$ 1,893
Net (loss) income per share attributable to NuVasive, Inc.:
Earnings Per Share, Basic	$ (0.04)	$ 0.17	$ (0.52)	$ 0.04
Earnings Per Share, Diluted	$ (0.04)	$ 0.16	$ (0.52)	$ 0.04
Weighted average shares outstanding:
Basic (in shares)	46,990	44,572	46,546	44,339
Diluted (in shares)	46,990	47,220	46,546	46,387